Find Research Projects

Search results

• Sir Asher Joel Foundation

  Davis, G.

  1/01/12 → 31/12/99

  Project: Other

• $181million - DFCRC: Digital Finance Cooperative Research Centre

  Foley, S.

  12/09/21 → 1/11/31

  Project: Research

• Fred Stephens Fellowship in Colorectal Surgery

  Lam, V.

  26/05/21 → 31/12/30

  Project: Research

• ENRITI: Energy and Natural Resources Innovation and Technology Research Initiative

  Soliman Hunter, T., Wilson, S. & Strezov, V.

  13/07/20 → 31/12/30

  Project: Research

• Blue Economy Cooperative Research Centre -Participants Agreement

  Abbassi, R., Bagnall, D., Salehi, F. & Li, M.

  1/01/20 → 30/06/29

  Project: Research

• XL-Chem: Synthesizing our future

  Karuso, P. & Franck, X.

  5/10/20 → 29/12/28

  Project: Other

• MISC - AAO: A Macquarie University home for the Australian Astronomical Observatory Instrumentation Group and A Collaborative Approach to Establishing a National Optical Astronomy Instrumentation Capability

  Steel, M.

  1/07/18 → 30/06/28

  Project: Research

• ICCRP: The International and Canadian Child Rights Partnership

  Doel-Mackaway, H.

  30/05/21 → 31/12/27

  Project: Research

• ARC Centre of Excellence for Plant Success in Nature and Agriculture

  Beveridge, C., Cooper, M., Brodribb, T., Waterhouse, P. M., Wright, I., Bowman, J., Burrage, K., Donovan, D., Foo, E., Jordan, D., Hammer, G., Henry, R., Holland, B., Ortiz-Barrientos, D., Sherman, B., Smith, S., Weller, J., Bett, K., Holbrook, N., Li, J., Lunn, J., Messina, C., Morris, G., Rieseberg, L., Taylor, J. & Trevaskis, B.

  4/12/20 → 3/12/27

  Project: Research

• COESB: ARC Centre of Excellence in Synthetic Biology

  Paulsen, I., Filipovska, A., Parker, R., Nielsen, L. K., Neilan, B. A., Alexandrov, K., Jackson , C., Wodak, J., Rackham, O., Marcellin, E., Gillings, M., Rogers, W., Lee, L., Packer, N., O'Hara, I. M., Speight, R., Vickers, C. E., Beliaev, A., Scott, C., Lacey, J., Mankad, A., Calvert, J., Thomas, G., Rodriguez-Concepcion, M., Fleishman, S., Koepke, M., Ball, M., Turner, N. J., Borneman, A. R., Holowko, M., Goold, H., Ellis, T., Mitchell, L. A. & Dai, J.

  9/11/20 → 8/11/27

  Project: Research

• SmartCrete CRC

  Clark, S., Wu, S., Salehi, F., Bishop, M., Trueck, S., Linnenluecke, M., Mukhopadhyay, S., Sheng, M., Beheshti, A., Hansen, S., Dekker, P., Jackson, S., Asadniaye Fard Jahromi, M., Wiggins, M., Ams, M., Withford, M., Beheshti, A., Dafforn, K., Giri, P., Sofronov, G., Taheri, S. & Abbassi, R.

  Macquarie University

  21/09/20 → 20/09/27

  Project: Research

• NSW RAAP CoESB: NSW RAAP Funding for ARC Centre of Excellence in Synthetic Biology (CoESB)

  Paulsen, I.

  1/02/20 → 1/02/27

  Project: Research

• The Australian Centre for Excellence in Antarctic Science

  King, M., Armand, L., England, M. H., Aitken , A., Antoine, D., Gayen, B., Goodwin, I., Selway, K., White, D., Williams, S. B., Galton-Fenzi, B. K., Rintoul, S., Post, A., Claustre, H., baptiste Sallee, J., Crosta, X., Thompson, D., Whitehouse, P., Aoki, S., Waugh, D., Edwards, T., Lee, S. W., Dutrieux, P., Griffies, S., Levermann, A., Fricker, H., Kulessa, B., Wolff, E. W., Scambos, T., Wåhlin, A., Gladstone, R., Naveira-Garabato, A., Levine, N., Yokoyama, Y., Doney, S., Van Den Broeke, M. R. & Toole, J.

  1/01/20 → 26/04/21

  Project: Research

• SmartCrete CRC

  Clark, S., Wu, S., Salehi, F., Bishop, M., Trueck, S., Linnenluecke, M., Mukhopadhyay, S., Sheng, M., Beheshti, A., Hansen, S., Dekker, P., Jackson, S., Asadniaye Fard Jahromi, M., Wiggins, M., Ams, M., Withford, M., Beheshti, A., Dafforn, K., Giri, P., Sofronov, G., Taheri, S. & Abbassi, R.

  1/01/20 → 31/12/26

  Project: Research

• Macquarie University Centre for Reading Bequest

  Kohnen, S., Castles, A., McArthur, G. & Banales, E.

  1/09/21 → 31/12/26

  Project: Research

• MK6482-012: An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with MK-6482 and Lenvatinib (MK-7902), or MK-1308A in Combination with Lenvatinib, versus Pembrolizumab and Lenvatinib, as First line Treatment in Participants with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

  Gurney, H., Chapman, N. & Zhang, A.

  11/02/21 → 26/11/26

  Project: Research

• Harmonic analysis: singular integrals, function spaces and related topics

  Duong, X.

  31/10/21 → 30/10/26

  Project: Research

• GS-US-548-5916: A Phase 2 Study of Magrolimab Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma

  Park, J., Sabanathan, D., Xia, C., Kim, S. & Chapman, N.

  3/08/21 → 29/07/26

  Project: Research

• LeapForward: Evaluating a multimodal psychosocial approach to workplace injury management

  Jones, T. & Dean, C.

  1/07/21 → 30/06/26

  Project: Research

• Cooperative Research Centre for Smart Satellite Technologies and Analytics (SmartSat CRC)

  Reisenfeld, S., Cetin, E., Abbas, R., Kong, Y., Vesilo, R., Esselle, K. & Hashmi, R.

  8/01/20 → 30/06/26

  Project: Other

• FT210100241: Seeking 'Closure' in Unsolved Homicide Cases

  Rossmanith, K.

  27/06/22 → 26/06/26

  Project: Research

• SAMETA: A Phase III, Open Label, Randomised, Controlled, Multi-Centre Study of Savolitinib plus Durvalumab versus Sunitinib and Savolitinib plus Durvalumab versus Durvalumab in Participants with MET-Driven, Unresectable and Locally Advanced, or Metastatic Papillary Renal Cell Carcinoma (PRCC)

  Gurney, H., Zhang, A. & Chapman, N.

  6/09/21 → 4/06/26

  Project: Research

• Keynote-B49: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Locally Recurrent Inoperable or Metastatic Breast Cancer

  Sabanathan, D. & Chapman, N.

  20/06/21 → 27/05/26

  Project: Research

• SHR3162-III-305: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined with Abiraterone Acetate and Prednisone (AA-P) versus Placebo Combined with AA-P as First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

  Gurney, H., Chapman, N. & Zhang, A.

  1/09/21 → 27/05/26

  Project: Research

• CONTACT-02: A phase 3 randomized, open label, controlled study of cabozantinib (XL184) in combination with Atezolizumab vs second novel hormonal therapy in subjects with high-risk, metastatic castration-resistant prostate cancer

  Gurney, H., Zhang, A. & Chapman, N.

  3/09/21 → 29/04/26

  Project: Research

• ACT16849: A Phase 2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR-707) combined with other anticancer therapies for the treatment of participants with lung cancer or pleural mesothelioma

  Park, J., Chapman, N. & Tan, P.

  13/05/21 → 15/04/26

  Project: Research

• TAR-200: Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guerin (BCG) who are Ineligible for or Elected Not to Undergo Radical Cystectomy

  Patel, M., Chapman, N. & Tan, P.

  13/08/21 → 15/04/26

  Project: Research

• Investigator Grant: Creating an Empirically Based Classification System for Mental Illness

  Forbes, M.

  1/03/21 → 28/02/26

  Project: Research

• USYD Led: Reducing the Morbidity of Head and Neck Cancer Treatment

  Clark, J., Gupta, R., Lee, J., Ashford, B. G., Ranson, M., Boyer, M., Rizos, H., Yang, J. Y. H., Suaning, G. J. & Wallace, G. G.

  1/02/21 → 31/01/26

  Project: Research

• Screening and Risk Reduction for Dementia in Primary Care

  Wuthrich, V.

  1/01/21 → 31/12/25

  Project: Research

• Who am I? Disrupted self-identity development in early adulthood and intrusive thoughts and behaviours

  Wong, S. F. & Rapee, R.

  1/01/22 → 31/12/25

  Project: Research

• Coordinating Committee, International Lithosphere Program 'Lithosphere of East Antarctica'

  Reading, A., Selway, K. & King, M.

  1/01/21 → 31/12/25

  Project: Research

• Novel nanotechnology strategies for drug delivery to the brain and preclinical evaluation of therapies

  Shi, B.

  1/01/21 → 31/12/25

  Project: Research

• Macquarie University Centre for Reading

  Castles, A.

  21/06/21 → 31/12/25

  Project: Research

• IN210100008: Building An Indigenist Health Humanities Collective

  Bond, C., Whop, L., Brough, M., Mukandi, B., Macoun, A., Newhouse, G., Drummond, A., McQuire, A., Stajic, J. & Kajlich, H.

  26/02/21 → 31/12/25

  Project: Research

• Michael Morgan HDR Scholarship in brain AVM research

  Stoodley, M. & McRobb, L.

  1/06/21 → 31/12/25

  Project: Research

• Therapeutic drug actions in the nervous system

  Connor, M.

  13/12/20 → 31/12/25

  Project: Research

• WIO-R2R: WIO-Ridge to Reef: An Ecosystem Based Approach to Biodiversity Conservation in the Western Indian Ocean

  Mbui, M.

  1/01/16 → 31/12/25

  Project: Research

• FoxG1 Syndrome PhD Scholarship

  Delerue, F.

  29/06/21 → 31/12/25

  Project: Research

• A Multi-Centre Randomised Controlled Trial of Polysomnographic Titration of Non-Invasive Ventilation in Motor Neurone Disease

  Berlowitz, D. J., Rowe, D., Howard, M., Piper, A., Graco, M., Braat, S., Singh , B., Sousa , T. V., Lannin , N., Gan, R., Ordonez Artunduaga, P., Pan, J., Barnes, K., Aiyappan, V., Curtin , D., Wu, P. & Birks, C.

  1/02/21 → 31/12/25

  Project: Research

• Keynote B61: MK3475-B61 - A Phase 2, Single-arm, Open-label Clinical Trial of Pembrolizumab Plus Lenvatinib in Participants with First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (nccRCC) (KEYNOTE-B61)

  Gurney, H., Chapman, N. & Tan, P.

  1/02/21 → 10/12/25

  Project: Research

• Art & Wonder: Young Children and Contemporary Art. A collaboration between the Museum of Contemporary Art Australia and Macquarie University

  Britt, C., Palmer, A., Shepherd, W., Robertson, J., Davis, B. & Lavina, L.

  1/09/17 → 1/12/25

  Project: Research

• WO42133/TRIO038: TRIO038: A randomized, multicenter, open-label, two-arm, phase II neoadjuvant study evaluating the activity, efficacy, safety and pharmacokinetics of GDC-9545 in combination with palbociclib compared with anastrozole with palbociclib for postmenopausal women with operable estrogen receptor positive (ER+) and HER-2 negative (HER-2-) untreated breast cancer.

  Sabanathan, D. & Chapman, N.

  18/12/20 → 26/11/25

  Project: Research

• AMPLITUDE: A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

  Gurney, H. & Chapman, N.

  30/11/20 → 15/10/25

  Project: Research

• MK6842-013: Phase 2 Study of MK-6482 in Participants With Advanced Renal Cell Carcinoma

  Gurney, H., Zhang, A. & Chapman, N.

  13/11/20 → 15/10/25

  Project: Research

• Next generation adjuvants for advanced immunotherapies

  Garcia-Bennett, A.

  3/01/20 → 3/10/25

  Project: Research

• EFC15935: A randomized, multicentre, double-blind phase 3 study of SAR439859 plus palbociclib versus letrozole plus palbociclib for the treatment of patients with ER (+), HER2 (-) breast cancer who have not received prior systemic anti-cancer treatment for advanced disease

  Sabanathan, D., Park, J. & Chapman, N.

  30/09/20 → 30/09/25

  Project: Research

• CS3002-101: A phase 1, open-label, multi-dose, dose escalation and expansion study to investigate the safety, tolerability, pharmacokinetics and anti-tumor activities of CS3002, a CDK4/6 inhibitor, in subjects with advance solid tumors

  Park, J., Sabanathan, D. & Chapman, N.

  30/10/20 → 24/09/25

  Project: Research

• Bayer 20510: A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of novel anti-hormonal therapy (NAH) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of NAH

  Gurney, H. & Chapman, N.

  1/12/20 → 10/09/25

  Project: Research

• Sydney Quantum Academy Scholarship_Volz/Mahajan

  Volz, T.

  1/09/21 → 31/08/25

  Project: Research